DavidRBerkMD
Dermatology • Saint Louis, MOPediatric Dermatology
Director, Clinical Development - Dermatology, Allergan, Inc, Irvine, CA; Teledermatologist (volunteer/unpaid), Direct Dermatology, Bay Area, CA
Dr. Berk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
Suite 5B
Saint Louis, MO 63110Phone+1 314-362-2643Fax+1 314-747-8693
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Dermatology, 2008 - 2009
Washington University/B-JH/SLCH ConsortiumResidency, Dermatology, 2005 - 2008- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 2004 - 2005
Stanford University School of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2008 - 2025
MO State Medical License 2009 - 2025- American Board of Dermatology Dermatology
- American Board of Dermatology Pediatric Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema Start of enrollment: 2019 Dec 23
Publications & Presentations
PubMed
- 122 citationsCutis laxa: A reviewDavid R. Berk, Danette D. Bentley, Susan J. Bayliss, Anne C. Lind, Zsolt Urban
Journal of the American Academy of Dermatology. 2012-05-01 - 18 citationsSafety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study.David M. Pariser, Lawrence Green, Edward Lain, Carsten Schmitz, Amy S Chinigo
The Journal of Clinical and Aesthetic Dermatology. 2019-11-01 - 54 citationsTrial of Roflumilast Cream for Chronic Plaque PsoriasisMark Lebwohl, Kim A. Papp, Linda Stein Gold, Melinda Gooderham, Leon H Kircik
The New England Journal of Medicine. 2020-07-15
Press Mentions
Common Features of Periocular TineaMarch 14th, 2011
Topical Oxymetazoline Hydrochloride 1.0% Effectively Reduces Persistent Facial Erythema of Rosacea on Day 1August 2nd, 2018
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
